Loading…
Underlying
Underlying Price
$8.48
Type
Call
Strike
12.5
Expiration
Nov 27, 2026
DTE
38d
Moneyness
OTM
Intrinsic
$0.00
IBRX 12.5 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 23, 2026 | 3d | $0.09 | -55.00% | 1 | 16 |
| Oct 30, 2026 | 10d | $0.32 | +0.00% | 3 | 2 |
| Nov 6, 2026 | 17d | $0.10 | -74.36% | 1 | 22 |
| Nov 13, 2026 | 24d | $0.52 | +0.00% | 1 | 1 |
| Nov 27, 2026 | 38d | — | — | 0 | 0 |
IBRX Profile
immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.